← back to search

Vijay H. Shah

Mayo Clinic · US
Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Alcohol Consumption and Health Effects, Liver Disease and Transplantation, and Liver physiology and pathology.
h-index
97
citations
31,837
works
625
NIH funding
primary concept
email

Recent publications

AI-driven synthetic data generation for accelerating hepatology research: A study of the United Network for Organ Sharing (UNOS) database.
2026cited by 3position: contributordoi
Detection of undiagnosed liver cirrhosis via AI-enabled electrocardiogram: a pragmatic, cluster-randomized clinical trial.
2026cited by 1position: contributordoi
Author Correction: Detection of undiagnosed liver cirrhosis via AI-enabled electrocardiogram: a pragmatic, cluster-randomized clinical trial.
2026cited by 0position: contributordoi
A lifecycle governance and learning health system framework for trustworthy, generalizable, and sustainable human-ai partnership in clinical practice: Lessons from the asthma-guidance and prediction system (A-GPS)
Journal of the National Medical Association 2026cited by 0position: contributordoi
Angiocrine signaling drives liver fibrosis: From mechanism to early clinical translation
Cell 2026cited by 0position: contributordoi
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease
Nature Reviews Gastroenterology & Hepatology 2025cited by 14position: middledoi
The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints.
2025cited by 9position: contributordoi
AI-Cirrhosis-ECG (ACE) score for predicting decompensation and liver outcomes
JHEP Reports 2025cited by 8position: contributordoi
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease.
2025cited by 7position: contributordoi
Three-Dimensional Vector MR Elastography for Evaluating Tissue Mechanical Heterogeneity to Assess Liver Disease Progression.
2025cited by 6position: contributordoi
Targeting Hepatic Stellate Cell PD-L1 Alters Liver Inflammation and Fibrosis in CCl4 Liver Injury Mouse Model
Cellular and Molecular Gastroenterology and Hepatology 2025cited by 6position: middledoi
Analysis and Validation of Image Search Engines in Histopathology
IEEE Reviews in Biomedical Engineering 2025cited by 6position: contributordoi
Reducing alcohol-associated liver disease burden in the general population
˜The œLancet. Gastroenterology & hepatology 2025cited by 3position: lastdoi
Training and Performance of an Electrocardiogram-Enabled Machine Learning Model for Detection of Advanced Chronic Liver Disease.
2025cited by 1position: contributordoi
Corticosteroids in severe alcohol-associated hepatitis. Not so fast: A systematic review of randomized controlled trials.
2025cited by 1position: contributordoi
Interleukin-1 Inhibition in Alcohol-associated Hepatitis: Are We Hitting the Right Target?
Clinical Gastroenterology and Hepatology 2025cited by 0position: contributordoi
Reimagining the Electronic Health Record to Reduce Administrative Burden
Mayo Clinic Proceedings 2025cited by 0position: contributordoi
Introducing STRAND: A Foundational Sequence Transformer for Range Adaptive Nucleotide Decoding
2025cited by 0position: contributordoi
Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease
Journal of Hepatology 2024cited by 124position: middledoi
Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes
Journal of Hepatology 2024cited by 91position: contributordoi
Angiocrine signaling in sinusoidal homeostasis and liver diseases.
2024cited by 56position: contributordoi
Epidemiology of liver diseases: global disease burden and forecasted research trends
Science China Life Sciences 2024cited by 49position: middledoi
Glycolysis in hepatic stellate cells coordinates fibrogenic extracellular vesicle release spatially to amplify liver fibrosis
Science Advances 2024cited by 29position: middledoi
The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints
The American Journal of Gastroenterology 2024cited by 20position: middledoi
Glycolysis in hepatic stellate cells coordinates fibrogenic extracellular vesicle release spatially to amplify liver fibrosis.
2024cited by 19position: contributordoi
Artificial Intelligence-Enabled Stool Analysis for Lactulose Titration Assistance in Hepatic Encephalopathy Through a Smartphone Application.
2024cited by 7position: contributordoi
Alcohol-Associated Liver Disease
American Journal of Gastroenterology 2024cited by 1position: contributordoi
Every sheriff needs a deputy: Targeting non-parenchymal cells to treat hepatic fibrosis
Journal of Hepatology 2024cited by 0position: contributordoi
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis
JHEP Reports 2023cited by 31position: middledoi
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis
JHEP Reports 2023cited by 29position: contributordoi

Grants

CAREER: O-DSM: An Open Dynamic Spectrum Management Framework for Enhanced 6G Coexistence
NSF2443035$397,3562025–2030PIRePORTER
Collaborative Research: Research Infrastructure: CCRI: New: Distributed Space and Terrestrial Networking Infrastructure for Multi-Constellation Coexistence
NSF2529715$215,3142024–2027PIRePORTER
Collaborative Research: CIRC: Planning-C: O-Milli-RAN - An O-RAN-compliant, Softwarized mmWave Radio Stack with Flexible PHY and MAC
NSF2529615$40,0002024–2025PIRePORTER
Collaborative Research: CIRC: Planning-C: O-Milli-RAN - An O-RAN-compliant, Softwarized mmWave Radio Stack with Flexible PHY and MAC
NSF2346385$40,0002024–2025PIRePORTER
Collaborative Research: Research Infrastructure: CCRI: New: Distributed Space and Terrestrial Networking Infrastructure for Multi-Constellation Coexistence
NSF2235140$299,9892023–2025PIRePORTER

Frequent collaborators

· 76 papers (2019–2026)Douglas A. Simonetto · Loma Linda University22 papers (2019–2026)Patrick S. Kamath · Mayo Clinic in Florida19 papers (2013–2026)Ashwani K. Singal · University of Louisville12 papers (2013–2024) · 9 papers (2022–2026)Douglas A. Simonetto · Mayo Clinic8 papers (2014–2024)Juan Pablo Arab · Virginia Commonwealth University7 papers (2020–2025)Sheng Cao · Mayo Clinic6 papers (2019–2021) · 6 papers (2021–2026) · 6 papers (2020–2022)Harmeet Malhi · Mayo Clinic in Florida6 papers (2020–2023) · 6 papers (2019–2024)Arun J. Sanyal · Center for Systems Biology5 papers (2016–2025)Philippe Mathurin · Université Lille Nord de France5 papers (2016–2021)Nidhi Jalan-Sakrikar · Mayo Clinic in Florida5 papers (2020–2024)Tejasav S. Sehrawat · WinnMed5 papers (2021–2021)Puru Rattan · Mayo Clinic in Arizona5 papers (2022–2026)Enis Kostallari · Mayo Clinic5 papers (2019–2020)Mark Thursz · Imperial College London5 papers (2015–2022)Rohit Loomba · Indiana University – Purdue University Indianapolis4 papers (2015–2026)